Literature DB >> 33617289

Unilateral Axillary Lymphadenopathy After Coronavirus Disease (COVID-19) Vaccination.

Michaela Cellina1, Giovanni Irmici2, Gianpaolo Carrafiello3.   

Abstract

Entities:  

Year:  2021        PMID： 33617289     DOI： 10.2214/AJR.21.25683

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN： 0361-803X            Impact factor:   3.959


× No keyword cloud information.
  5 in total

Review 1.  Lymphadenopathy Following COVID-19 Vaccination: Imaging Findings Review.

Authors:  Pedram Keshavarz; Fereshteh Yazdanpanah; Faranak Rafiee; Malkhaz Mizandari
Journal:  Acad Radiol       Date:  2021-05-01       Impact factor: 3.173

Review 2.  COVID-19 vaccine-related axillary lymphadenopathy in breast cancer patients: Case series with a review of literature.

Authors:  Jihe Lim; Seun Ah Lee; Eun Kyung Khil; Sun-Ju Byeon; Hee Joon Kang; Jung-Ah Choi
Journal:  Semin Oncol       Date:  2021-10-26       Impact factor: 4.929

3.  Axillary lymph node imaging in mRNA, vector-based, and mix-and-match COVID-19 vaccine recipients: ultrasound features.

Authors:  Alba Cristina Igual-Rouilleault; Ignacio Soriano; Arlette Elizalde; Paola Leonor Quan; Alejandro Fernandez-Montero; Carolina Sobrido; Luis Pina
Journal:  Eur Radiol       Date:  2022-05-13       Impact factor: 7.034

4.  Quadrilateral space region inflammation and other incidental findings on shoulder MRI following recent COVID-19 vaccination: Three case reports.

Authors:  Matthew Eisenberg; Christopher Tingey; Oliver Fulton; Josh Owen; Travis Snyder
Journal:  Radiol Case Rep       Date:  2021-07-19

Review 5.  Lymphadenopathy post-COVID-19 vaccination with increased FDG uptake may be falsely attributed to oncological disorders: A systematic review.

Authors:  Khalifa Bshesh; Wafa Khan; Ahamed Lazim Vattoth; Emmad Janjua; Areej Nauman; Muna Almasri; Ateeque Mohamed Ali; Vinutha Ramadorai; Beshr Mushannen; Mai AlSubaie; Ibrahim Mohammed; Mais Hammoud; Pradipta Paul; Haya Alkaabi; Aliyaa Haji; Sa'ad Laws; Dalia Zakaria
Journal:  J Med Virol       Date:  2022-02-07       Impact factor: 20.693
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.